TLR3 and neoplasm: Accordingly, when we analyzed the human primary NSCLC specimens collected at Fondazione IRCCS Istituto Nazionale dei Tumori of Milan, which we recently investigated for TLR3 expression [13], a benefit from TLR3 tumor expression was observed only in subjects with adenocarcinoma, but not in patients with squamous carcinoma.